All Type of News
Celltrion awaits market authorization of Remsima from 52 countries
Celltrion, a local biopharmaceutical company, said Monday that it has awaited approval of Remsima from 52 countries as well as the European Medicines Agency (EMA).
Remsima is a biosimilar version of U.S. Merck’s Re...
Daewoong Pharm signs $5 million Easyef export deal
Local drug maker Daewoong Pharmaceutical said Monday it has signed a five million dollar agreement with the Egyptian company EGY-TEC to export its newly developed Easyef ointment for treatment of diabetic foot ulcer.
...
National university hospitals impose different room charges
The non-reimbursable room charges and MRI scan of national university hospital have been differently imposed, according to a lawmaker.
Rep. Nam Yoon-insoon of the main opposition Democratic United Party, citing the...
Drug makers eye popular OTC drugs
Some drug firms are rushing to copy popular over-the-counter drugs to soften the blow from government-mandated cuts in drug prices.
Their focus is centered around Yuyu Pharmaceutical’s anti-informatory agent ‘Venop...
Australia ranks first in per capita expense for OTC drug
Australia’ per capita expenditure for purchase of OTC drug stands at $104, the highest figure in Asia-Pacific countries, according to Veronita Rusli of Nicollas&Hall Company at the first Asia-Pacific Self-Medication I...
Two NHIC officials to be reprimanded
The National Health Insurance Corporation (NHIC) will take disciplinary action against its two officials upon the demand from the Board of Audit and Inspection (BAI).
This comes as the BAI said they violated the gu...
Measures urged over re-pricing of drugs having extended indication
The Board of Audit and Inspection (BAI) called on the Ministry of Health and Welfare to readjust the price of insurance drugs whose indications are extended.
According to the BAI, which investigated the prices of 1...
Yungin forges strategic tie-up with Novacell
Yungjin Pharmaceutical said Monday that it has forged a strategic alliance with Novacell Technology in an effort to develop new proteomix based biomarkers.
The deal with Novacell is expected to help enhance coopera...
Multinational firms to speed up M&A moves
Multinational drug companies will speed up their M&A moves as part of their efforts to beef up competitiveness.
The U.S. generics company Alvogen Group recently purchased 50.5 percent in shares of mid-sized Kunwha ...
Ilyang, Daewoong sign deal to sell Supect
Ilyang Pharmaceutical Co. said Friday it established a strategic partnership with Daewoong Pharmaceutical Co. to sell Supect, a newly-developed drug for myelogenous leukemia by Ilyang, in Korea.
Under the deal, Ily...
